Evolution and phenotypic characterization of whole HBV genome in compliant patients experiencing unexplained entecavir treatment failure-Reference-Cited by-同舟云学术

Evolution and phenotypic characterization of whole HBV genome in compliant patients experiencing unexplained entecavir treatment failure

Published:2021-08 Issue: Volume:192 Page:105106
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Marlet Julien,Lier Clément,Roch Emmanuelle,Moreau Alain,Combe Benjamin,Handala Lynda,Lefeuvre Sandrine,Maugey Morgan,Elkrief Laure,d’Alteroche Louis,Potier Pascal,Brand Denys,Gaudy-Graffin Catherine

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference65 articles.

1. A novel hepatitis B virus (HBV) subgenotype D (D8) strain, resulting from recombination between genotypes D and E, is circulating in Niger along with HBV/E strains;Abdou Chekaraou;J. Gen. Virol.,2010

2. Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B virus e antigen-positive and -negative strains;Amini-Bavil-Olyaee;J. Virol.,2010

3. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection;Barnaba;J. Immunol. Baltim. Md,1989

4. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation;Bock;Gastroenterology,2002

5. Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients;Brost;World J. Gastroenterol.,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreased expression of HBV surface antigen (HBsAg) with sK122R and sV96A co-mutation is associated with an ineffective antibody response in a chronic hepatitis B patient;Infection, Genetics and Evolution;2023-07

2. Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?;Journal of Virology;2022-05-11

3. Traitement de l’hépatite B chronique par ténofovir : aspects virologiques et pharmacologiques;Virologie;2022-05-01

4. Immunosuppressants/rituximab;Reactions Weekly;2021-11